In studies in which
viagra versus medicine was administered to patients on antihypertensive music, there was no step-up in management discontinuations owing to adverse events in patients receiving
viagra. In a musical composition by Kloner
et al., the frequency of treatment-related adverse events potentially related to the reduction of BP (hypotension, flushing, dizziness) was not different in patients receiving
sildenafil plus no antihypertensive medicines, versus
sildenafil plus 1, 2 or â¥3 antihypertensive medicines. Furthermore, there were no patients who developed inflammatory disease, coronary blood vessel disease or myocardial infarction when
sildenafil was administered on top of antihypertensive medicament. In a acquisition by Pickering
et al., discourse adverse events related to
sildenafil, such as head ache, flushing, dyspepsia and others, were similar among patients who were taking multiple antihypertensive medications to those that had been reported for patients on
viagra not on antihypertensives.
Also, there was no increased relative frequency of adverse events (except flushing) in patients receiving tadalafil and base hit or multiple antihypertensive agents. In studies assessing the use of vardenafil in patients on antihypertensive medicines, there was no growth in adverse events. Thus, PDE5 inhibitors can be safely administered with usual antihypertensive agents including diuretics, beta blockers, calcium blockers and angiotensin anatomical structure blockers.